Declining Rates of Treatment-Related Mortality in Patients with Newly-diagnosed AML Given “Intense” Induction Regimens: A Report from SWOG and MD Anderson

Less-intense remission induction regimens for adults with newly-diagnosed AML aim to reduce treatment-related mortality (TRM), here defined as death within 4 weeks after starting induction therapy. This assumes that TRM rates are similar to the 15-20% observed 20 years ago. Herein we test this assum...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Leukemia
Autors principals: Othus, Megan, Kantarjian, Hagop, Petersdorf, Stephen, Ravandi, Farhad, Godwin, John, Cortes, Jorge, Pierce, Sherry, Erba, Harry, Faderl, Stefan, Appelbaum, Frederick R., Estey, Elihu
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4457325/
https://ncbi.nlm.nih.gov/pubmed/23760400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2013.176
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars